4.7 Article

Small-fiber neuropathy in patients with ALS

期刊

NEUROLOGY
卷 76, 期 23, 页码 2024-2029

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31821e553a

关键词

-

资金

  1. German Research Council (DFG) [WE 1406/13-1]
  2. Biogen Idec
  3. German Research Foundation (DFG)
  4. German Ministry for Education and Research (BMBF)
  5. European Union
  6. Belgian Science Policy (BelSPo)
  7. German Society for Muscle Diseases (DGM)
  8. Jackstedt Foundation
  9. Interdisciplinary Center for Clinical Research of RWTH Aachen University
  10. Genzyme Corporation
  11. Bayer Schering Pharma
  12. German Research Foundation [SFB 581]
  13. Interdisciplinary Center for Clinical Research of the University of Wurzburg
  14. Teva Pharmaceutical Industries Ltd.
  15. Lundbeck Inc.
  16. Boehringer Ingelheim
  17. sanofi-aventis
  18. Ono Pharmaceutical Co. Ltd.
  19. Santhera Pharmaceuticals
  20. Knopp Neurosciences Inc.
  21. Schwarz Pharma
  22. GlaxoSmithKline
  23. Oxford University
  24. Cambridge University
  25. Fresenius Medical Care
  26. Trophos SA
  27. Takeda Pharmaceutical Company Limited
  28. Allon Therapeutics, Inc.
  29. Deutsche Forschungsgemeinschaft (DFG)
  30. Packard Foundation
  31. Fritz Thyssen Stiftung

向作者/读者索取更多资源

Objective: To investigate the involvement of the epidermal small sensory fibers in the neurodegenerative process in amyotrophic lateral sclerosis (ALS). Methods: In the present study, skin biopsies of 28 patients with ALS were obtained at an average of 34 months after disease onset by history. Protein gene product 9.5 (PGP9.5) immunohistochemistry findings were compared to 17 age-matched controls. The primary endpoint of the study was to evaluate the decrease in the density of small intraepidermal nerve fibers and to compare the prevalence of small-fiber neuropathy in patients with ALS and in controls. Results: We found a significant reduction in epidermal nerve fiber density in the distal calf of patients with ALS (4.8 +/- 3.7 fibers/mm vs 12.2 +/- 4.6 in age-matched controls, p < 0.0001). The extent of fiber loss was age-dependent. Also, the number of subjects with small-fiber neuropathy was significantly higher in the ALS group than in the controls (79% vs 12%). Correspondingly, mild sensory symptoms including diffuse dysesthesias, paresthesias, and hypesthesia were found in 7 patients. In 17 biopsies of patients with ALS, but only in 2 controls, we saw larger (>1.5 mu m in diameter) focal swellings of epidermal axons resembling spheroids, suggesting trafficking defects. Conclusions: These results indicate that small, distal epidermal nerve fibers are involved in this disease, supporting the concept of distal axonopathy in ALS. Neurology (R) 2011;76:2024-2029

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Cytokine expression profiles in white blood cells of patients with small fiber neuropathy

Luisa Kress, Nadine Egenolf, Claudia Sommer, Nurcan Uceyler

Summary: This study found higher gene expression of the anti-inflammatory cytokines IL-2, IL-8, and TNF in white blood cells of patients with SFN compared to healthy controls. The combination of these three cytokines had high diagnostic accuracy. Furthermore, female patients showed higher gene expression levels of IL-8 and TNF. IL-2 gene expression was negatively correlated with current pain intensity, and IL-10 gene expression differed between different types of pain.

BMC NEUROSCIENCE (2023)

Article Clinical Neurology

Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage

Luise Appeltshauser, Helena Junghof, Julia Messinger, Janis Linke, Axel Haarmann, Ilya Ayzenberg, Panoraia Baka, Johannes Dorst, Anna L. Fisse, Thomas Grueter, Valerie Hauschildt, Alexander Joerk, Frank Leypoldt, Mathias Maeurer, Edgar Meinl, Sebastian Michels, Jeremias Motte, Kalliopi Pitarokoili, Mark Stettner, Carmen Villmann, Marc Weihrauch, Gabriel S. Welte, Inga Zerr, Katrin G. Heinze, Claudia Sommer, Kathrin Doppler

Summary: Autoimmune neuropathy associated with antibodies against pan-neurofascin is a new subtype of nodo-paranodopathy that is associated with high morbidity and mortality. The underlying pathology and long-term prognosis of this condition are not well understood. Understanding the pathogenic mechanism of this disease may have direct implications for its treatment.
Article Clinical Neurology

Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response

Marie Madlener, Christine Strippel, Franziska S. Thaler, Kathrin Doppler, Klaus P. Wandinger, Jan Lewerenz, Marius Ringelstein, Rosa Roessling, Til Menge, Jonathan Wickel, Christoph Kellingshaus, Sigrid Mues, Andrea Kraft, Andreas Linsa, Simone C. Tauber, Florian Then Berg, Stefan T. Gerner, Asterios Paliantonis, Alexander Finke, Josef Priller, Ingo Schirotzek, Marie Suesse, Kurt W. Suehs, Christian Urbanek, Makbule Senel, Claudia Sommer, Tania Kuempfel, Harald Pruess, Gereon R. Fink, Frank Leypoldt, Nico Melzer, Michael P. Malter

Summary: This study investigated 101 patients with suspected autoimmune neurological syndromes (AINS) associated with glutamic acid decarboxylase (GAD) antibodies. The results showed that immunotherapy had moderate effectiveness in these patients, and serum GAD antibody levels and intrathecal GAD antibody synthesis did not predict clinical characteristics or treatment outcomes.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

Article Endocrinology & Metabolism

Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter study

Jonas Muentze, Kolja Lau, Markus Cybulla, Eva Brand, Tereza Cairns, Lora Lorenz, Nurcan Ueceyler, Claudia Sommer, Christoph Wanner, Peter Nordbeck

Summary: This study investigated therapy adherence and patient-reported outcomes in Fabry disease patients receiving migalastat treatment. The results showed that almost all patients demonstrated high therapy adherence, and there was improvement in pain and physical limitations during the treatment.

MOLECULAR GENETICS AND METABOLISM (2023)

Letter Neurosciences

Reduced T-cell densities in cranial nerves of patients who died with SARS-CoV-2 infection

Juliane Bremer, Johannes Friemann, Saskia von Stillfried, Peter Boor, Joachim Weis

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Impact of Hypermannosylation on the Structure and Functionality of the ER and the Golgi Complex

Patricia Franzka, Svenja Caren Schueler, Takfarinas Kentache, Robert Storm, Andrea Bock, Istvan Katona, Joachim Weis, Katrin Buder, Christoph Kaether, Christian A. Hubner

Summary: Proteins of the secretory pathway undergo glycosylation in the ER and Golgi apparatus. Mutations in GMPPA can cause AAMR syndrome with various symptoms. Loss of GMPPA leads to Golgi fragmentation, altered protein abundance, reduced furin activity, and increased retention of alpha-DG.

BIOMEDICINES (2023)

Letter Cardiac & Cardiovascular Systems

Tafamidis for cardiac transthyretin amyloidosis: application in a real-world setting in Germany

Caroline Morbach, Aikaterini Papagianni, Sandra Ihne-Schubert, Vladimir Cejka, Maximilian Steinhardt, Georg Fette, Melissa Held, Andreas Geier, Hermann Einsele, Stefan Frantz, Stefan Knop, Claudia Sommer, Stefan Stoerk

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Editorial Material Clinical Neurology

European Journal of Neurology will flip to open access in January 2024

Didier Leys, Claudia Sommer, Paul Boon

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

Local Inflammatory Mediators Involved in Neuropathic Pain

Patricia Garcia-Fernandez, Colette Reinhold, Nurcan Ueceyler, Claudia Sommer

Summary: Polyneuropathy (PNP) refers to diseases of the peripheral nervous system, with 50% of cases presenting with neuropathic pain. Certain types of PNP show pain restricted to the distal leg skin, indicating a local regulatory process leading to pain. This study suggests that a pro-inflammatory pathway mediated by NF-κB may contribute to pain development in patients with painful PNP. Our findings support the hypothesis of local inflammatory processes involved in pain in PNP, and suggest disrupted anti-inflammatory pathways in inflammatory PNP involving TRPV1 and SIRT1.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Clinical Neurology

Neurofilament light chain levels indicate acute axonal damage under bortezomib treatment

Nadine Cebulla, Daniel Schirmer, Eva Runau, Leon Flamm, Sonja Gommersbach, Helena Stengel, Xiang Zhou, Hermann Einsele, Ann-Kristin Reinhold, Bruno Rogalla von Bieberstein, Daniel Zeller, Heike Rittner, K. Martin Kortuem, Claudia Sommer

Summary: This study aimed to evaluate the relationship between serum levels of neurofilament light chain (NfL) and the characteristics of BTZ-induced peripheral neuropathy (BIPN). The study found that both patients with ongoing BTZ treatment and patients with previous BTZ treatment had higher serum NfL levels compared to controls, and patients with ongoing BTZ treatment had higher NfL levels than patients with past treatment. Serum NfL levels correlated with electrophysiological measures of axonal damage in the group with ongoing BTZ treatment.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Dermal Real-Time Quaking-Induced Conversion Is a Sensitive Marker to Confirm Isolated Rapid Eye Movement Sleep Behavior Disorder as an Early alpha-Synucleinopathy

Anastasia Kuzkina, Celine Panzer, Aline Seger, Daniela Schmitt, Jonas Roessle, Sebastian R. Schreglmann, Henrike Knacke, Elena Salabasidou, Antonia Kohl, Elisabeth Sittig, Michael Barbe, Daniela Berg, Jens Volkmann, Claudia Sommer, Wolfgang H. Oertel, Eva Schaeffer, Michael Sommerauer, Annette Janzen, Kathrin Doppler

Summary: The study assessed the use of RT-QuIC method to detect alpha-synuclein aggregation in skin biopsy samples of iRBD patients. It was found that 97.4% of iRBD patients, 87.2% of PD patients, and 13% of controls showed aggregation of alpha-synuclein. RT-QuIC was more sensitive but less specific compared to immunohistochemistry.

MOVEMENT DISORDERS (2023)

Article Immunology

Systemic inflammatory markers in patients with polyneuropathies

Patricia Garcia-Fernandez, Klemens Hoefflin, Antonia Rausch, Katharina Strommer, Astrid Neumann, Nadine Cebulla, Ann-Kristin Reinhold, Heike Rittner, Nurcan Ueceyler, Claudia Sommer

Summary: In patients with peripheral neuropathies (PNP), the presence of neuropathic pain is independent of the etiology and is found in 50% of the cases. The pathophysiology of pain in PNP is poorly understood, but inflammation has been implicated in neurodegeneration, regeneration, and pain. A comprehensive analysis of inflammatory markers in blood and cerebrospinal fluid (CSF) of PNP patients and controls revealed no major differences in systemic inflammation, but specific cytokines or lipids showed variations. The study highlights the importance of CSF analysis in patients with peripheral neuropathies.

FRONTIERS IN IMMUNOLOGY (2023)

Article Anesthesiology

Future perspectives: the next fifty years of the International Association for the Study of Pain

Claudia Sommer, Margarita Calvo, Fernando Cervero, John D. Loeser

Summary: The International Association for the Study of Pain has made important contributions to the understanding and treatment of pain through various activities and is committed to reducing the burden of pain worldwide.
暂无数据